Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a global health burden with increasing incidence, poor prognosis and limited therapeutic options. Natural killer (NK) cells exhibit potent anti-tumoral activity and therefore represent potential targets for immunotherapeutic approaches in HCC treatment. However, the...
Main Authors: | Charlotte Rennert, Catrin Tauber, Pia Fehrenbach, Kathrin Heim, Dominik Bettinger, Özlem Sogukpinar, Anita Schuch, Britta Franziska Zecher, Bertram Bengsch, Sven A. Lang, Peter Bronsert, Niklas K. Björkström, Stefan Fichtner-Feigl, Michael Schultheiss, Robert Thimme, Maike Hofmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/6/1369 |
Similar Items
-
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
by: Joseph Yoo, et al.
Published: (2018-04-01) -
HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
by: Zijun Ge, et al.
Published: (2019-06-01) -
DEMOGRAPHICS AND CORRELATION OF RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS PRESENTING TO A TERTIARY CARE FACILITY IN PAKISTAN
by: Hafsa Rashid, et al.
Published: (2021-04-01) -
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
by: Mohamed A. Abdel Mohsen, et al.
Published: (2014-09-01) -
CD8<sup>+</sup> T Cell Responses during HCV Infection and HCC
by: Maike Hofmann, et al.
Published: (2021-03-01)